Drug Schedules (Drugs & Cosmetics Act)

Drug Schedules under the Drugs & Cosmetics Act 1940 / Rules 1945

1. Definition & legislative framework

• The Drugs and Cosmetics Act, 1940 is the parent statute regulating the import, manufacture, distribution and sale of drugs and cosmetics in India; the operational detail sits in the subordinate Drugs and Cosmetics Rules, 1945 (notified 21st December 1945) ([D&C Rules 1945, CDSCO consolidated text]).
• A "Schedule" is an appendix to the Rules: the Act/Rules contain the enabling sections and rules, while the Schedules (A to Y) carry the substantive lists, standards, forms, fees and conditions referenced by those rules ([D&C Rules 1945]).
  • Schedules are therefore the "lookup tables" of Indian drug law — each rule that needs a list (of prescription drugs, of GMP requirements, of fees, of clinical-trial requirements) points to a named Schedule.
  • Schedules can be amended/added by gazette notification (G.S.R.) without amending the parent Act — this is how Schedule H1 was inserted in 2013 (G.S.R. 588(E)) ([CDSCO G.S.R. 588(E), 30-08-2013]).
• Regulatory architecture (who enforces): the Central Drugs Standard Control Organization (CDSCO) under the Drugs Controller General of India (DCGI) is the central authority (import, new-drug approval, standards); State Drugs Control Authorities / State Licensing Authorities licence and inspect manufacture and retail/wholesale sale ([D&C Rules 1945]; CDSCO).
• Why a schedule system exists at all — the regulatory logic is the same one G&G traces for the US Food, Drug & Cosmetic Act: legislation evolves reactively after public-health disasters, progressively tightening control over who may make, sell and dispense a drug, proportional to its hazard (G&G 14e Ch.1, pp.13–14).
  • US precedent (for contrast, G&G 14e Ch.1, p.13–14): Pure Food and Drugs Act 1906 (adulteration/misbranding only) → 1938 Food, Drug & Cosmetic Act after >100 deaths from "elixir sulfanilamide" (diethylene-glycol solvent) → mandatory safety/NDA → Harris–Kefauver Amendments 1962 after the thalidomide/phocomelia catastrophe → mandatory proof of efficacy + risk–benefit documentation.
  • The Indian schedule system is the domestic analogue: graded control keyed to a drug's potential for harm, abuse, or need for professional supervision.